Top

World Journal of Surgery

Published in:

01-11-2009

Clinical Outcome of Malignant Biliary Obstruction Caused by Metastatic Gastric Cancer

Authors: Kazuhiro Migita, Akihiko Watanabe, Tetsuya Yoshioka, Shoichi Kinoshita, Takao Ohyama

Published in: World Journal of Surgery | Issue 11/2009

Abstract

Background

The clinical outcome of malignant biliary obstruction caused by metastatic gastric cancer remains unclear. This study was designed to evaluate the clinical outcome and predictive factors of survival in patients who underwent percutaneous transhepatic biliary drainage (PTBD) for malignant biliary obstruction caused by metastatic gastric cancer.

Methods

Between April 1997 and March 2006, 38 consecutive patients with malignant biliary obstruction caused by metastatic gastric cancer were retrospectively analyzed. All patients underwent PTBD.

Results

After PTBD, serum bilirubin levels significantly decreased in 29 (76%) of 38 patients. Pruritus, fever, jaundice, anorexia, abdominal pain, and general fatigue improved significantly in 100%, 100%, 78%, 64%, 53%, and 48% of patients, respectively. Early complications related to the intervention occurred in ten patients. Seven patients developed symptoms of recurrent jaundice or cholangitis. Overall median survival was 79 days, and 6-month and 1-year survival rates after PTBD were 39.5% and 13.2%, respectively. Serum bilirubin level after PTBD (P < 0.0001), chemotherapy after PTBD (P < 0.0001), and performance status at presentation (P = 0.0363) were found to be independent predictors of survival.

Conclusion

PTBD with metallic stent placement is a safe and effective palliation for patients with malignant biliary obstruction caused by metastatic gastric cancer. Our results suggest that patients in good clinical condition are candidates for aggressive treatment with a combination of PTBD with metallic stent placement and chemotherapy.

Papachristou D, Fortner JG (1978) Biliary obstruction after gastrectomy for carcinoma of the stomach. Surg Gynecol Obstet 147:401–404PubMed

Lokich JJ, Kane RA, Harrison DA et al (1987) Biliary tract obstruction secondary to cancer: management guidelines and selected literature review. J Clin Oncol 5:969–981PubMed

Anderson ID, Manson JM, Martin DF et al (1993) Relief of metastatic biliary obstruction by stent placement: is it worthwhile? Surg Oncol 2:113–117PubMedCrossRef

Rieber A, Brambs HJ (1997) Metallic stents in malignant biliary obstruction. Cardiovasc Intervent Radiol 20:43–49PubMedCrossRef

Inal M, Akgül E, Aksungur E et al (2003) Percutaneous self-expandable uncovered metallic stents in malignant biliary obstruction. Complications, follow-up and reintervention in 154 patients. Acta Radiol 44:139–146PubMedCrossRef

Indar AA, Lobo DN, Gilliam AD et al (2003) Percutaneous biliary metal wall stenting in malignant obstructive jaundice. Eur J Gastroenterol Hepatol 15:915–919PubMedCrossRef

Brountzos EN, Ptochis N, Panagiotou I et al (2007) A survival analysis of patients with malignant biliary strictures treated by percutaneous metallic stenting. Cardiovasc Intervent Radiol 30:66–73PubMedCrossRef

Kim GE, Shin HS, Seong JS et al (1994) The role of radiation treatment in management of extrahepatic biliary tract metastasis from gastric carcinoma. Int J Radiat Oncol Biol Phys 28:711–717PubMed

Makino T, Fujitani K, Tsujinaka T et al (2008) Role of percutaneous transhepatic biliary drainage in patients with obstructive jaundice caused by local recurrence of gastric cancer. Hepatogastroenterology 55:54–57PubMed

10.

Chu KM, Law S, Branicki FJ et al (1998) Extrahepatic biliary obstruction by metastatic gastric carcinoma. J Clin Gastroenterol 27:63–66PubMedCrossRef

11.

Lee BH, Chin SY, Kim SA et al (1995) Obstructive jaundice in gastric carcinoma: cause, site, and relationship to the primary lesion. Abdom Imaging 20:307–311PubMedCrossRef

12.

Iwasaki M, Furuse J, Yoshino M et al (1996) Percutaneous transhepatic biliary drainage for the treatment of obstructive jaundice caused by metastases from nonbiliary and nonpancreatic cancers. Jpn J Clin Oncol 26:465–468PubMed

13.

Brountzos EN, Petropoulos E, Kelekis NL et al (1999) Malignant biliary obstruction: management with percutaneous metallic stent placement. Hepatogastroenterology 46:2764–2771PubMed

14.

van Delden OM, Laméris JS (2008) Percutaneous drainage and stenting for palliation of malignant bile duct obstruction. Eur Radiol 18:448–456PubMedCrossRef

15.

Okamoto T, Yanagisawa S, Fujioka S et al (2006) Is metallic stenting worthwhile for biliary obstruction due to lymph node metastases? J Surg Oncol 94:614–618PubMedCrossRef

16.

Kawamoto H, Ishii Y, Nakagawa M et al (2003) Analysis of longterm survivors with expandable metallic stent inserted for malignant biliary stenosis. J Hepatobiliary Pancreat Surg 10:95–100PubMed

17.

Marsh WH, Cunningham JT (1992) Endoscopic stent placement for obstructive jaundice secondary to metastatic malignancy. Am J Gastroenterol 87:985–990PubMed

Title: Clinical Outcome of Malignant Biliary Obstruction Caused by Metastatic Gastric Cancer
Authors: Kazuhiro Migita
Akihiko Watanabe
Tetsuya Yoshioka
Shoichi Kinoshita
Takao Ohyama
Publication date: 01-11-2009
Publisher: Springer-Verlag
Published in: World Journal of Surgery / Issue 11/2009
Print ISSN: 0364-2313
Electronic ISSN: 1432-2323
DOI: https://doi.org/10.1007/s00268-009-0186-0

At a glance: The STEP trials

Springer Medicine

Clinical Outcome of Malignant Biliary Obstruction Caused by Metastatic Gastric Cancer

Abstract

Background

Methods

Results

Conclusion

At a glance: The STEP trials

Springer Medicine

Abstract

Background

Methods

Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 11/2009

Prospective Study of Intra-Abdominal Pressure Following Major Elective Abdominal Surgery

Trainee Surgeons Do Not Cause More Conversions in Laparoscopic Colorectal Surgery if They Are Well Supervised

Familial Parathyroid Tumors: Diagnosis and Management

Comparison of Invasiveness Between Laparoscopy-Assisted Total Gastrectomy and Open Total Gastrectomy

Peer-Reviewed, Evidence-Based Analysis of Vitamin D and Primary Hyperparathyroidism

Molecular Genetics of Parathyroid Disease